{
  "3404046": "BRONCHIAL THERMOPLASTY NOTE\nDate: [REDACTED]\nPatient: [REDACTED] | MRN: [REDACTED] | Age: 48F\nAttending: Dr. Andrew Miller, MD\nLocation: [REDACTED]\n\nINDICATION: Severe persistent asthma (FEV1 65%, on high-dose ICS/LABA, omalizumab, history of 3 exacerbations past year). Selected for bronchial thermoplasty after multidisciplinary review.\n\nPROCEDURE: Bronchial thermoplasty - Session 2 of 3 (Left Lower Lobe)\n\nANESTHESIA: Moderate sedation\n\nPROCEDURE DETAILS:\nUsing the Alair System (Boston Scientific), bronchial thermoplasty performed in the left lower lobe.\n\nTreatment Sites:\n- LB6: 15 activations\n- LB7: 8 activations\n- LB8: 12 activations\n- LB9: 14 activations\n- LB10: 11 activations\n\nTotal activations: 60\n\nEach activation delivered radiofrequency energy at 18.5 watts for 10 seconds at sequential 5mm intervals per standard protocol.\n\nPOST-PROCEDURE: Patient observed for 4 hours. Mild transient chest tightness resolved with bronchodilator. No significant adverse events.\n\nPLAN: Session 3 (RLL) in 3 weeks.\n\nDr. Andrew Miller, MD"
}
